NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL
Pharmaceutical Science Advances · 2026-12 · 4 · 100111
DOI: 10.1016/j.pscia.2026.100111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Lizhi Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Shando…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China.
- Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.
- Department of Hematology, Shandong Provincial Third Hospital, Jinan, Shandong, China.
Förderung
- National Natural Science Foundation of China
- Shandong Province Natural Science Foundation
Zitieren
APA
Shi, L., Huang, X., Han, X., Ning, C., Zhao, X., Li, H., Yu, Z., & Han, Q. (2026). NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL. Pharmaceutical Science Advances, 4, 100111. https://doi.org/10.1016/j.pscia.2026.100111
Vancouver
Shi L, Huang X, Han X, Ning C, Zhao X, Li H, et al. NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL. Pharmaceutical Science Advances. 2026;4:100111. doi:10.1016/j.pscia.2026.100111
BibTeX
@article{Shi2026,
author = {Shi, Lizhi and Huang, Xuezhu and Han, Xiao and Ning, Chenchen and Zhao, Xinyi and Li, Haohao and Yu, Zhe and Han, Qiuju},
title = {NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL},
journal = {Pharmaceutical Science Advances},
year = {2026},
volume = {4},
pages = {100111},
doi = {10.1016/j.pscia.2026.100111}
}
EUVIMED